生命科学资讯

Rainbows, pickleball and puppies: Inside the ‘enduring activism’ and ‘cautious optimism’ at ASH 2025

FDA is taking another look at safety of approved RSV antibodies

Eli Lilly earmarks $6B for GLP-1 pill factory in Alabama

Thermo Fisher Expands Bioprocess Design Centers Across Asia - Lab Manager

Medline sets terms for massive $5.37B Nasdaq IPO

FDA qualifies 1st AI drug development tool for reading MASH images

Teleflex inks $2B in divestment deals for OEM, urology and acute care units

Agilent, Danaher, Thermo Fisher new buys at Goldman Sachs (A:NYSE) - Seeking Alpha

FDA's probe of Covid-19 vaccines expands into adults

#ASH25: New data from Gilead, J&J set up a bispecific, CAR-T rivalry

Does Surging Genomics Consumables Demand Reshape The Bull Case For Illumina’s Recurring Revenue Engine (ILMN)? - Yahoo Finance

Lonza Group, Catalent, and Recipharm Lead the $12.5 Billion Inhaled Drugs Contract Manufacturing Mar - pharmiweb.com

J&J-backed Cellular Origins raises $40M for cell therapy manufacturing

Novartis notches another win for drug acquired in MorphoSys deal

Pfizer adds heft to obesity pipeline in $2B Yaopharma deal

Crescent, Kelun in two-way deal, including PD-1/VEGF bispecific

Aimedbio debuts with $48M Kosdaq IPO

Kazia raises AU$50M to advance PI3K/mTOR inhibitor paxalisib

14 psoriasis therapies projected to launch in China by 2027

SanegeneBio raises $110M in follow-up to metabolic deal with Lilly